TRACON Pharma Terminates Phase 3 TAPPAS Trial - Quick Facts

TRACON Pharmaceuticals, Inc. (TCON) announced Friday that its Phase 3 TAPPAS trial was terminated for futility based on the recommendation of the Independent Data Monitoring Committee (IDMC).

from RTT - Biotech http://bit.ly/2v6tBh3
via IFTTT